Clinical Trial Update: Cadherin 3(CDH3)-Targeted PET in Lung Malignant Tumors

View source ↗

Summary

A recruiting clinical trial at Peking University People's Hospital is evaluating a cadherin-3 (CDH3) targeted PET imaging agent for lung malignant tumors, inclu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Neoplasms
• Non-small Cell Lung Cancer
• Pulmonary Nodules

Drugs mentioned

• CDH3-targeted PET imaging agent

Snippet

Sponsor: Peking University People's Hospital | Conditions: Non-Small Cell Lung Cancer, Malignant Neoplasm | Status: RECRUITING